RNF126 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of RNF126, a RING finger E3 ubiquitin ligase that plays a critical role in the ubiquitin-proteasome system (UPS), a major pathway for protein degradation in cells. RNF126 is involved in the post-translational modification of proteins by facilitating the transfer of ubiquitin molecules to specific substrate proteins, marking them for degradation by the proteasome. This process is essential for maintaining protein homeostasis within the cell, regulating protein turnover, and controlling the levels of key signaling molecules. RNF126 is also implicated in various cellular processes, including DNA repair, cell cycle regulation, and the response to stress. By inhibiting RNF126, researchers can disrupt these ubiquitination processes, offering a powerful tool to study the specific roles of RNF126 in protein regulation and cellular function.
In research, RNF126 inhibitors are valuable tools for exploring the molecular mechanisms by which ubiquitination controls protein stability and activity. By blocking RNF126 activity, scientists can investigate how the inhibition affects the degradation of RNF126 substrate proteins and the subsequent impact on cellular pathways, such as those involved in cell cycle progression, signal transduction, and stress responses. This inhibition allows researchers to study the role of RNF126 in the broader context of the ubiquitin-proteasome system, providing insights into how specific E3 ligases contribute to the selective degradation of proteins and the maintenance of cellular homeostasis. Additionally, RNF126 inhibitors enable the examination of the interactions between RNF126 and other components of the ubiquitination machinery, shedding light on the complex regulatory networks that govern protein ubiquitination and degradation. Through these studies, the use of RNF126 inhibitors enhances our understanding of the critical functions of E3 ligases in cellular biology, the regulation of protein turnover, and the broader implications of ubiquitin-mediated processes in maintaining cellular health and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can indirectly affect RNF126 function by inhibiting protein degradation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, another proteasome inhibitor, might indirectly modulate RNF126 activity through its impact on protein degradation. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide and its derivatives, known for modulating E3 ligase activity, may indirectly influence RNF126. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
A derivative of Thalidomide, Lenalidomide can modulate the ubiquitin-proteasome system, potentially affecting RNF126. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Similar to Lenalidomide, Pomalidomide may have indirect effects on RNF126 through its impact on E3 ligases. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
HSP90 inhibitors can destabilize various client proteins, potentially affecting RNF126 stability and function. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN4924 inhibits NEDD8-activating enzyme, which can indirectly influence RNF126's E3 ligase activity. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin, a specific proteasome inhibitor, may have an indirect impact on RNF126-mediated protein degradation. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
While primarily targeting MDM2, Nutlin-3 can indirectly influence ubiquitin ligase activity, potentially affecting RNF126. | ||||||